PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: Summary of the literature and implications for genetic testing

American Heart Journal

Volumn 161, Issue 1, 2011, Pages 165-171

  Landstrom, Andrew P ^a,b   Adekola, Babatunde A ^a   Bos, J Martijn ^b   Ommen, Steve R ^c   Ackerman, Michael J ^b,c  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLAMBAN;

ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DNA SEQUENCE; FAMILY HISTORY; FEMALE; GENETIC ANALYSIS; GENETIC CODE; GENETIC SCREENING; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ALLELES; CALCIUM-BINDING PROTEINS; CARDIOMYOPATHY, HYPERTROPHIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MUTATION; PEDIGREE; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 78650272451     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2010.08.001     Document Type: Article

References (29)

1. Maron B.J., Gardin J.M., and Flack J.M. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study Circulation 92 1995 785 789
2. Maron B., Roberts W., and McAllister H. Sudden death in young athletes Circulation 62 1980 218 229 (Pubitemid 10035639)
3. Maron B., Epstein S., and Roberts W. Causes of sudden death in competitive athletes J Am Coll Cardiol 7 1986 204 214 (Pubitemid 16132479)
4. Van Driest S.L., Jaeger M.A., and Ommen S.R. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 602 610
5. Van Driest S.L., Ellsworth E.G., and Ommen S.R. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy Circulation 108 2003 445 451
6. Van Driest S.L., Vasile V.C., and Ommen S.R. Mutations and compound heterozygosity in hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 1903 1910
7. Landstrom A.P., Weisleder N., and Batalden K.B. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans J Mol Cell Cardiol 42 2007 1026 1035 (Pubitemid 46829202)
8. Chiu C., Tebo M., and Ingles J. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy J Mol Cell Cardiol 43 2007 337 343 (Pubitemid 47301938)
9. Landstrom A.P., Parvatiyar M.S., and Pinto J.R. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C J Mol Cell Cardiol 45 2008 281 288
10. Simmerman H.K., Collins J.H., and Theibert J.L. Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains J Biol Chem 261 1986 13333 13341
11. Inui M., Chamberlain B.K., and Saito A. The nature of the modulation of Ca2+ transport as studied by reconstitution of cardiac sarcoplasmic reticulum J Biol Chem 261 1986 1794 1800 (Pubitemid 17205016)
12. Haghighi K., Kolokathis F., and Pater L. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human J Clin Invest 111 2003 869 876 (Pubitemid 37074962)
13. Gollob M.H., Green M.S., and Tang A.S.L. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome N Engl J Med 344 2001 1823 1831 (Pubitemid 32538695)
14. Gollob M.H., Seger J.J., and Gollob T.N. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy Circulation 104 2001 3030 3033
15. Sakuraba H., Oshima A., and Fukuhara Y. Identification of point mutations in the alpha-galactosidase A gene in classical and atypical hemizygotes with Fabry disease Am J Hum Genet 47 1990 784 789 (Pubitemid 20384293)
16. Nishino I., Fu J., and Tanji K. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) Nature 406 2000 906 910 (Pubitemid 30664268)
17. Yang Z., McMahon C.J., and Smith L.R. Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children Circulation 112 2005 1612 1617 (Pubitemid 41324523)
18. Medin M., Hermida-Prieto M., and Monserrat L. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation Eur J Heart Fail 9 2007 37 43 (Pubitemid 46074476)
19. Minamisawa S., Sato Y., and Tatsuguchi Y. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy Biochem Biophys Res Commun 304 2003 1 4 (Pubitemid 36434184)
20. Santos D., Medeiros A., and Brum P. No evidence for an association between the -36A>C phospholamban gene polymorphism and a worse prognosis in heart failure BMC Cardiovasc Disord 9 2009 33
21. Haghighi K., Chen G., and Sato Y. A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids Hum Mutat 29 2008 640 647 (Pubitemid 351614588)
22. Schmitt J.P., Kamisago M., and Asahi M. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban Science 299 2003 1410 1413 (Pubitemid 36254657)
23. Haghighi K., Kolokathis F., and Gramolini A.O. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy Proc Natl Acad Sci U S A 103 2006 1388 1393 (Pubitemid 43191175)
24. Charron P., Villard E., and Sebillon P. Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey Heart 90 2004 842 846 (Pubitemid 39005922)
25. Hoigné P., Attenhofer Jost C.H., and Duru F. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy Int J Cardiol 111 2006 413 422 (Pubitemid 44205296)
26. Ackerman M.J., and Landstrom A.P. Detection of subclinical Fabry disease in patients presenting with hypertrophic cardiomyopathy J Am Coll Cardiol 50 2007 2404 2405
27. Kalemi T., Efthimiadis G., and Zioutas D. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a northern Greek population Biochem Genet 43 2005 637 642 (Pubitemid 43029745)
28. Fokstuen S., Lyle R., and Munoz A. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy Hum Mutat 29 2008 879 885 (Pubitemid 351794139)
29. Kapa S., Tester D.J., and Salisbury B.A. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants Circulation 120 2009 1752 1760